Related Experiment Video
Updated: May 6, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
von Willebrand factor and coronary heart disease: prospective study and meta-analysis
P H Whincup1, J Danesh, M Walker
1Department of Public Health Sciences, St George's Hospital Medical School, London, UK.
Insights
Higher circulating von Willebrand factor concentrations are linked to increased coronary heart disease risk in men. Further research is needed to confirm if this association is causal.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Epidemiology
Background:
- von Willebrand factor (vWF) is crucial for hemostasis.
- Elevated vWF levels have been implicated in thrombotic disorders.
- Its role in coronary heart disease (CHD) risk in the general population requires further elucidation.
Purpose of the Study:
- To prospectively investigate the association between circulating von Willebrand factor concentrations and the risk of developing coronary heart disease.
- To contextualize findings through a meta-analysis of existing population-based prospective studies.
Main Methods:
- A nested case-control study within a prospective cohort of 5661 men aged 40-59 years.
- Measurement of baseline von Willebrand factor in serum samples from 625 CHD cases and 1266 controls.
- Statistical analysis including adjustments for age, town, and cardiovascular risk factors, alongside a meta-analysis.
Main Results:
- Men in the highest tertile of vWF had a significantly higher odds ratio (1.83) for CHD compared to the lowest tertile, even after risk factor adjustment.
- The association remained significant when excluding individuals with pre-existing CHD at baseline.
- A meta-analysis of relevant studies yielded a combined odds ratio of 1.5 for CHD risk associated with elevated vWF.
Conclusions:
- Circulating von Willebrand factor concentrations show a prospective association with incident coronary heart disease.
- The findings suggest vWF may be a significant risk marker for CHD.
- Further investigation is warranted to determine the causal role of vWF in the pathogenesis of coronary heart disease.
Aims:
To determine whether circulating von Willebrand factor concentrations are prospectively related to risk of coronary heart disease in the general population.
Methods And Results:
We measured baseline von Willebrand factor values in the stored serum samples of 625 men with major coronary events and in 1266 controls 'nested' in a prospective study of 5661 men aged 40-59 years, recruited from general practices in 18 British towns in 1978-1980 and followed up for 16 years for fatal coronary heart disease and non-fatal myocardial infarction. We conducted a meta-analysis of previous relevant studies to place our results in context. Men in the top third of baseline von Willebrand factor values (tertile cutoff >126 IU.dl(-1)) had an odds ratio for coronary heart disease of 1.83 (95% confidence interval 1.43-2.35; 2P <0.0001) compared with those in the bottom third (tertile cutoff <90 IU.dl(-1)), after adjustments for age and town. The odds ratio was little changed after further adjustment for risk factors (1.82, 95% CI 1.37-2.41), and was not significantly different in an analysis restricted to the 404 cases and 1007 controls without baseline evidence of coronary heart disease (odds ratio 1.53, 95% CI 1.10-2.12). A meta-analysis of all relevant population-based prospective studies (including the present study) yielded a combined odds ratio of 1.5 (95% CI 1.1-2.0). von Willebrand factor values were strongly correlated with Helicobacter pylori seropositivity and circulating concentrations of C-reactive protein (2 P<0.0001 for each), but not with smoking, blood lipids, or most other measured risk factors.
Conclusion:
Though circulating von Willebrand factor concentrations may be associated with incident coronary heart disease, further studies are needed to determine the extent to which this is causal.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies